相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Racial/Ethnic Differences Among Tumor-Infiltrating Lymphocytes in Breast Cancer Tumors
Surbhi Bansil et al.
ONCOLOGIST (2023)
Pyrotinib plus capecitabine for patients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases (PERMEATE): a multicentre, single-arm, two-cohort, phase 2 trial
Min Yan et al.
LANCET ONCOLOGY (2022)
Survival after neoadjuvant therapy with trastuzumab-lapatinib and chemotherapy in patients with HER2-positive early breast cancer: a meta-analysis of randomized trials
V Guarneri et al.
ESMO OPEN (2022)
Neoadjuvant Trastuzumab and Pyrotinib for Locally Advanced HER2-Positive Breast Cancer (NeoATP): Primary Analysis of a Phase II Study
Wenjin Yin et al.
CLINICAL CANCER RESEARCH (2022)
Cost-effectiveness of trastuzumab biosimilar combination therapy and drug wastage as first-line treatment for HER2-positive metastatic breast cancer
John Hang Leung et al.
BREAST (2022)
Neoadjuvant pyrotinib, trastuzumab, and docetaxel for HER2-positive breast cancer (PHEDRA): a double-blind, randomized phase 3 trial
Jiong Wu et al.
BMC MEDICINE (2022)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Financial Toxicity and Cancer Care #409
Ramy Sedhom et al.
JOURNAL OF PALLIATIVE MEDICINE (2021)
Existing and Emerging Breast Cancer Detection Technologies and Its Challenges: A Review
Ahmad Ashraf Abdul Halim et al.
APPLIED SCIENCES-BASEL (2021)
Financial toxicity in cancer care: origins, impact, and solutions
Hannah R. Abrams et al.
TRANSLATIONAL BEHAVIORAL MEDICINE (2021)
Pertuzumab Plus High-Dose Trastuzumab in Patients With Progressive Brain Metastases and HER2-Positive Metastatic Breast Cancer: Primary Analysis of a Phase II Study
Nancy U. Lin et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk
H. Amarens Geuzinge et al.
JAMA ONCOLOGY (2020)
Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial
Cristina Saura et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Breast Cancer Treatment A Review
Adrienne G. Waks et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Pyrotinib combined with capecitabine in women with HER2+metastatic breast cancer previously treated with trastuzumab and taxanes: A randomized phase III study.
Zefei Jiang et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
The Financial Burden and Distress of Patients with Cancer: Understanding and Stepping-Up Action on the Financial Toxicity of Cancer Treatment
Pricivel M. Carrera et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Cancer incidence and mortality in China, 2014
Wanqing Chen et al.
CHINESE JOURNAL OF CANCER RESEARCH (2018)
Tucatinib with capecitabine and trastuzumab in advanced HER2-positive metastatic breast cancer with and without brain metastases: a non-randomised, open-label, phase 1b study
Rashmi Murthy et al.
LANCET ONCOLOGY (2018)
Optimal treatment of early stage HER2-positive breast cancer
Sonia Pernas et al.
CANCER (2018)
Socioeconomic status and breast cancer treatment
Marie S. Dreyer et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Safety and efficacy of trastuzumab emtansine (T-DM1) in 399 patients with central nervous system metastases: Exploratory subgroup analysis from the KAMILLA study
F. Montemurro et al.
CANCER RESEARCH (2017)
The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in Italy
F. Perrone et al.
ANNALS OF ONCOLOGY (2016)
Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial
Martine Piccart-Gebhart et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Expenditure and financial burden for common cancers in China: a hospital-based multicentre cross-sectional study
Hui-Yao Huang et al.
LANCET (2016)
Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Arlene Chan et al.
LANCET ONCOLOGY (2016)
A review of systematic reviews of the cost-effectiveness of hormone therapy, chemotherapy, and targeted therapy for breast cancer
Vakaramoko Diaby et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Trastuzumab emtansine (T-DM1) versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer and central nervous system metastases: a retrospective, exploratory analysis in EMILIA
I. E. Krop et al.
ANNALS OF ONCOLOGY (2015)
Safety and Efficacy of Neratinib in Combination With Capecitabine in Patients With Metastatic Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
Cristina Saura et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
US Incidence of Breast Cancer Subtypes Defined by Joint Hormone Receptor and HER2 Status
Nadia Howlader et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Trends in breast cancer incidence and mortality in the United States: implications for prevention
Adetunji T. Toriola et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study
Thomas Bachelot et al.
LANCET ONCOLOGY (2013)
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial
Jose Baselga et al.
LANCET (2012)
Clinical outcome of patients with brain metastases from HER2-positive breast cancer treated with lapatinib and capecitabine
G. Metro et al.
ANNALS OF ONCOLOGY (2011)
Central Nervous System Metastases in Patients with HER2-Positive Metastatic Breast Cancer: Incidence, Treatment, and Survival in Patients from registHER
Adam M. Brufsky et al.
CLINICAL CANCER RESEARCH (2011)
Delivering affordable cancer care in high-income countries
Richard Sullivan et al.
LANCET ONCOLOGY (2011)
The Role of Combination Chemotherapy in the Treatment of Patients with Metastatic Breast Cancer
Jens Huober et al.
BREAST CARE (2009)
Repeated observation of breast tumor subtypes in independent gene expression data sets
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
分享论文
